1. Home
  2. ICU vs ENLV Comparison

ICU vs ENLV Comparison

Compare ICU & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SeaStar Medical Holding Corporation

ICU

SeaStar Medical Holding Corporation

HOLD

Current Price

$0.90

Market Cap

4.5M

Sector

Health Care

ML Signal

HOLD

Logo Enlivex Therapeutics Ltd.

ENLV

Enlivex Therapeutics Ltd.

SELL

Current Price

$1.11

Market Cap

4.0M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
ICU
ENLV
Founded
2018
2005
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5M
4.0M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
ICU
ENLV
Price
$0.90
$1.11
Analyst Decision
Analyst Count
0
0
Target Price
★ $10.00
N/A
AVG Volume (30 Days)
★ 238.6K
95.1K
Earning Date
11-11-2026
12-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $1,234,000.00
N/A
Revenue This Year
$72.04
N/A
Revenue Next Year
$38.06
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 814.07
N/A
52 Week Low
$0.22
$0.16
52 Week High
$5.38
$7.64

Technical Indicators

Market Signals
Indicator
ICU
ENLV
Relative Strength Index (RSI) 26.56 49.47
Support Level N/A $1.02
Resistance Level $3.53 $1.26
Average True Range (ATR) 0.20 0.12
MACD -0.05 -0.05
Stochastic Oscillator 8.73 20.54

Price Performance

Historical Comparison
ICU
ENLV

About ICU SeaStar Medical Holding Corporation

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.

About ENLV Enlivex Therapeutics Ltd.

Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.

Share on Social Networks: